Corizon Health competitors

Otto is an experienced executive in the healthcare services sector, specifically with Medicare Advantage global risk contracting, correctional healthcare, home healthcare and hospitalists groups. Otto is part of the investment team responsible for sourcing and portfolio company oversight. Prior to Comvest, Otto was President and a shareholder of MCCI Group Holdings, a global risk provider to large health plans throughout the United States. He has also served as an executive and strategic advisor to Armor Correctional Healthcare, Atenda Home Health and Florida Acute Care Services amongst others. Otto began his career at KPMG. Otto received a B.A. in Accounting and an M.B.A. Summa Cum Laude from the University of Miami.

Daniel Slipkovich is a Chief Executive Officer at CAPELLA HEALTHCARE and is based in United States.

John Garbarino is a General Partner at Webster Equity Partners, Chairman/CEO at Epic Health Services, and Board Member at Occupational Health And Rehabilitation Inc and is based in Greater Boston. He has worked as Certified Public Accountant at EY, President and CEO at Eyetel Imaging Inc., and Executive Chairman at Epic Health Services. John attended Boston College Carroll School of Management, Boston College between 1970 and 1974, and Tuck School of Business at Dartmouth between 1978 and 1980.

Neil has served on Medidata Solutions' board of directors since 2002. He is also currently the president, chief executive officer of Golden Living, a leading provider of long-term care. Prior to joining Golden Living, Neil was the president and CEO of TorreyPines Therapeutics Inc., a clinical stage biopharmaceutical company, as well as president of Ingenix Pharmaceutical Services, a division of UHG, and a member of the UHG Executive Board. Additionally, he co-founded Worldwide Clinical Trials, a contract research organization, where he held the positions of president and chief executive officer until its acquisition by United Health Group in 1999. Neil held various senior positions with Boots Pharmaceuticals, Bayer Corporation, Bristol-Myers Squibb and Merck. He currently serves on the board of NeurogesX, a specialty pharmaceutical company. Neil has consulted more than a dozen pharmaceutical companies and served as member of the faculty in the Department of Psychiatry at the University of Connecticut and the University of California, Los Angeles. He holds a B.A. in Psychology from New York University and an M.D. from the Medical College of Wisconsin.

Mr. Kim Hollon N. is a Chief Executive Officer and President at Signature Healthcare Corporation and is based in United States.